Subrina Farah

766 total citations
20 papers, 227 citations indexed

About

Subrina Farah is a scholar working on Pulmonary and Respiratory Medicine, General Health Professions and Surgery. According to data from OpenAlex, Subrina Farah has authored 20 papers receiving a total of 227 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 7 papers in General Health Professions and 4 papers in Surgery. Recurrent topics in Subrina Farah's work include Renal cell carcinoma treatment (5 papers), Patient-Provider Communication in Healthcare (4 papers) and Bladder and Urothelial Cancer Treatments (3 papers). Subrina Farah is often cited by papers focused on Renal cell carcinoma treatment (5 papers), Patient-Provider Communication in Healthcare (4 papers) and Bladder and Urothelial Cancer Treatments (3 papers). Subrina Farah collaborates with scholars based in United States, Belgium and Denmark. Subrina Farah's co-authors include Mechelle Sanders, Kevin Fiscella, Toni K. Choueiri, Paul Winters, Wanling Xie, Supriya G. Mohile, Arlene O. Siefker‐Radtke, Jennifer K. Carroll, Bradley A. McGregor and Amishi Y. Shah and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Internal Medicine and PLoS ONE.

In The Last Decade

Subrina Farah

18 papers receiving 220 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Subrina Farah United States 8 76 70 64 45 44 20 227
Liang G. Qu Australia 9 53 0.7× 123 1.8× 61 1.0× 24 0.5× 46 1.0× 32 326
Bruce C. M. Wang United States 11 73 1.0× 34 0.5× 37 0.6× 21 0.5× 47 1.1× 15 289
Samir P. Desai United States 7 85 1.1× 54 0.8× 66 1.0× 53 1.2× 19 0.4× 12 297
Pietro Genova France 10 149 2.0× 95 1.4× 82 1.3× 30 0.7× 16 0.4× 24 265
Ali Al Khader Jordan 11 57 0.8× 39 0.6× 98 1.5× 26 0.6× 22 0.5× 49 332
Raphael Gotlieb Canada 11 98 1.3× 41 0.6× 44 0.7× 21 0.5× 91 2.1× 14 401
Chaoyi Zheng United States 10 95 1.3× 123 1.8× 64 1.0× 48 1.1× 30 0.7× 21 352
Alexander S. Qian United States 10 94 1.2× 68 1.0× 52 0.8× 21 0.5× 70 1.6× 44 329
Emel Kurtoğlu Türkiye 11 35 0.5× 152 2.2× 43 0.7× 20 0.4× 46 1.0× 33 354
Christian Vutuc Austria 11 35 0.5× 109 1.6× 82 1.3× 39 0.9× 73 1.7× 30 290

Countries citing papers authored by Subrina Farah

Since Specialization
Citations

This map shows the geographic impact of Subrina Farah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Subrina Farah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Subrina Farah more than expected).

Fields of papers citing papers by Subrina Farah

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Subrina Farah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Subrina Farah. The network helps show where Subrina Farah may publish in the future.

Co-authorship network of co-authors of Subrina Farah

This figure shows the co-authorship network connecting the top 25 collaborators of Subrina Farah. A scholar is included among the top collaborators of Subrina Farah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Subrina Farah. Subrina Farah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rotenstein, Lisa S., Liqin Wang, Subrina Farah, et al.. (2024). Looking Beyond Mortality Prediction: Primary Care Physician Views of Patients' Palliative Care Needs Predicted by a Machine Learning Tool. Applied Clinical Informatics. 15(3). 460–468. 1 indexed citations
2.
3.
Chikarmane, Sona A., et al.. (2023). Discriminative Factors of Malignancy of Ipsilateral Nonmass Enhancement in Women With Newly Diagnosed Breast Cancer on Initial Staging Breast MRI. Journal of Magnetic Resonance Imaging. 59(5). 1725–1739. 2 indexed citations
4.
Denize, Thomas, Subrina Farah, Alessia Cimadamore, et al.. (2021). Biomarkers of Angiogenesis and Clinical Outcomes to Cabozantinib and Everolimus in Patients with Metastatic Renal Cell Carcinoma from the Phase III METEOR Trial. Clinical Cancer Research. 28(4). 748–755. 12 indexed citations
5.
McLeod, Monsey, Subrina Farah, Tej Sheth, et al.. (2021). Designing a continuous data-driven feedback and learning initiative to improve electronic prescribing: an interdisciplinary quality improvement study. International Journal of Pharmacy Practice. 29(Supplement_1). i18–i19. 1 indexed citations
6.
Lalani, Aly‐Khan A., Ziad Bakouny, Subrina Farah, et al.. (2021). Assessment of Immune Checkpoint Inhibitors and Genomic Alterations by Body Mass Index in Advanced Renal Cell Carcinoma. JAMA Oncology. 7(5). 773–773. 20 indexed citations
7.
Hirsch, Laure, Subrina Farah, Ronan Flippot, et al.. (2021). Activity and safety of cabozantinib (cabo) in brain metastases (BM) from metastatic renal cell carcinoma (mRCC): An international multicenter study.. Journal of Clinical Oncology. 39(6_suppl). 310–310. 4 indexed citations
8.
Fiscella, Kevin, Margaret Noonan, Subrina Farah, et al.. (2020). Drug- and Alcohol-Associated Deaths in U.S. Jails. Journal of Correctional Health Care. 26(2). 183–193. 13 indexed citations
9.
Pomerantz, Mark M., Kim Leitzel, Subrina Farah, et al.. (2020). Plasma IL-8 and PD-L1 and overall survival in metastatic castration-resistant prostate cancer patients (mCRPC).. Journal of Clinical Oncology. 38(15_suppl). e17565–e17565. 3 indexed citations
10.
McGregor, Bradley A., Matthew T. Campbell, Wanling Xie, et al.. (2020). Phase II study of nivolumab and ipilimumab for advanced rare genitourinary cancers.. Journal of Clinical Oncology. 38(15_suppl). 5018–5018. 7 indexed citations
11.
McGregor, Bradley A., Matthew T. Campbell, Wanling Xie, et al.. (2020). Results of a multicenter, phase 2 study of nivolumab and ipilimumab for patients with advanced rare genitourinary malignancies. Cancer. 127(6). 840–849. 66 indexed citations
12.
Carroll, Jennifer K., Jonathan N. Tobin, Amneris E. Luque, et al.. (2019). “Get Ready and Empowered About Treatment” (GREAT) Study: a Pragmatic Randomized Controlled Trial of Activation in Persons Living with HIV. Journal of General Internal Medicine. 34(9). 1782–1789. 28 indexed citations
13.
Lalani, Aly‐Khan A., Ziad Bakouny, Subrina Farah, et al.. (2019). Efficacy of immune checkpoint inhibitors (ICI) and genomic alterations by body mass index (BMI) in advanced renal cell carcinoma (RCC). Annals of Oncology. 30. v396–v396. 4 indexed citations
14.
Carroll, Jennifer K., et al.. (2019). Addressing Medication Costs During Primary Care Visits: A Before–After Study of Team-Based Training. Annals of Internal Medicine. 170(9_Supplement). S46–S53. 15 indexed citations
15.
Sanders, Mechelle, et al.. (2018). Promoting MedlinePlus utilization in a federally qualified health center using a multimodal approach. Journal of the Medical Library Association JMLA. 106(3). 361–369. 1 indexed citations
16.
Carroll, Jennifer K., Kevin Fiscella, Andrea Cassells, et al.. (2018). Theoretical and Pragmatic Adaptation of the 5As Model to Patient-Centered Hypertension Counselling. Journal of Health Care for the Poor and Underserved. 29(3). 975–983. 5 indexed citations
17.
Fogarty, Colleen T., Paul Winters, & Subrina Farah. (2016). Improving patient-centered communication while using an electronic health record. The International Journal of Psychiatry in Medicine. 51(4). 379–389. 2 indexed citations
18.
Fiscella, Kevin, Paul Winters, Subrina Farah, Mechelle Sanders, & Supriya G. Mohile. (2015). Do Lung Cancer Eligibility Criteria Align with Risk among Blacks and Hispanics?. PLoS ONE. 10(11). e0143789–e0143789. 32 indexed citations
19.
Fiscella, Kevin, Julian Brown, Jennifer K. Carroll, et al.. (2015). Activation of persons living with HIV for treatment, the great study. BMC Public Health. 15(1). 1056–1056. 11 indexed citations
20.
Farah, Subrina, et al.. (2015). Age of First Infection of Pulmonary Tuberculosis in Dhaka Metropolitan City. Dhaka University Journal of Science. 62(1). 49–53.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Liang G. Qu Breakdown of academic impact, for papers by Bruce C. M. Wang Breakdown of academic impact, for papers by Samir P. Desai Breakdown of academic impact, for papers by Pietro Genova Breakdown of academic impact, for papers by Ali Al Khader Breakdown of academic impact, for papers by Raphael Gotlieb Breakdown of academic impact, for papers by Chaoyi Zheng Breakdown of academic impact, for papers by Alexander S. Qian Breakdown of academic impact, for papers by Emel Kurtoğlu Breakdown of academic impact, for papers by Christian Vutuc
Rankless by CCL
2026